The StepSmart Project: A Pedometer Based Phased Intervention to Encourage Physical Activity in Schools
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02455986|
Recruitment Status : Completed
First Posted : May 28, 2015
Last Update Posted : August 17, 2017
|Condition or disease||Intervention/treatment||Phase|
|Physical Activity Health Behavior Competitive Behavior Incentives||Behavioral: The StepSmart Challenge||Phase 1|
The intervention is separated into three main phases.
Phase One: A 10-week school competition using pedometers and a range of non-financial incentives e.g. t-shirts, pens, badges etc. (April - June 2015).
Phase Two: End of school competition but participants will still keep the pedometers. We will set them various challenges over the summer to keep active (July - Oct 2015).
Phase Three: Removal of all extrinsically motivation factors. Focus on PA maintenance.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||240 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Randomised Controlled Trial of a Pedometer Based Phased Intervention to Encourage Physical Activity in Schools: A Feasibility Study.|
|Actual Study Start Date :||April 2015|
|Actual Primary Completion Date :||October 2016|
|Actual Study Completion Date :||October 2016|
The intervention group includes 150 participants aged 12-14 across three schools. Each participant has been given a Fitbit Zip pedometer to wear for a six month period and enrolled on the StepSmart challenge. Participants within the intervention group will take part in two competitions during this period.
Prizes of low monetary value will be given to participants based on competition performance
Behavioral: The StepSmart Challenge
A six month pedometer based intervention designed to increase Physical Activity in school children
No Intervention: Control
The control group for the study involves approximately 90 participants aged 12 - 14. across two schools. Participants within the control group will complete the same measures as the intervention group including wearing an actigraph GT3X accelerometer for a seven day period and completing all questionnaires at the same time points as the intervention group.
- Change from baseline in physical activity as assessed by Actigraph accelerometer [ Time Frame: Baseline, 6 months and 1 year ]Actigraph accelerometer counts per minute and minutes of moderate and vigorous physical activity
- Change in mental wellbeing measured by the Warwick Edinburgh Mental Well-being Scale [ Time Frame: Baseline, 6 months and 1 year ]Warwick Edinburgh Mental Well-being Scale is a validated, self-report instrument assessing mental wellbeing. Possible scores range from range from 14-70, with higher scores indicating higher mental well-being
- Change in social support for physical activity measured by the social support for physical activity scale [ Time Frame: Baseline, 6 months and 1 year ]Social support for physical activity scale is a validated 5-item scale. Social support is measured as tghe sum of responses to four sub-scales including parental social support (3 items), parental encouragement (2 items), peer support (3 items), and teacher support (3 items). Each question is answered with a 4-point response format ranging from 1 (hardly ever or never) to 4 (every day).
- Change in future orientation and impulsivity measured using 8-item time preference scale [ Time Frame: Baseline, 6 months and 1 year ]A previously validated 8-item time preference scale is included. Responses are summed to obtain a a future orientation and impulsivity score. High scores reflect future time orientation and greater impulsivity in decision making.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02455986
|Principal Investigator:||Mark A Tully, PhD||Queen's University, Belfast|